Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...

Hologic HOLX has highlighted the role of its Panther Fusion platform in supporting the future growth of its Diagnostics business. Fusion is an add-on module to the base Panther system, providing a ...

Hologic has won clearance for the Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The Marlborough, MA-based company said it has also obtained CE marking in accordance ...

Hologic, Inc.’s HOLX fiscal first quarter of 2025 witnessed robust strength in the molecular diagnostics segment. The company's strategic initiatives look highly promising. Meanwhile, declining ...

I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu ...

Hologic’s HOLX Diagnostics unit, the largest by revenues, has been the most impacted by geopolitical headwinds this year. Cuts in USAID funding have affected its HIV testing business in Africa, while ...